"Human Growth Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.
| Descriptor ID |
D019382
|
| MeSH Number(s) |
D06.472.699.631.525.425.875 D12.644.548.691.525.425.875
|
| Concept/Terms |
Human Growth Hormone- Human Growth Hormone
- Growth Hormone, Human
- hGH (Human Growth Hormone)
- Somatropin (Human)
- Somatotropin (Human)
- Somatropin
|
Below are MeSH descriptors whose meaning is more general than "Human Growth Hormone".
Below are MeSH descriptors whose meaning is more specific than "Human Growth Hormone".
This graph shows the total number of publications written about "Human Growth Hormone" by people in this website by year, and whether "Human Growth Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 2 | 3 |
| 1999 | 2 | 2 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 1 | 4 |
| 2011 | 3 | 1 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 2 | 1 | 3 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human Growth Hormone" by people in Profiles.
-
Disparities in Growth Hormone Deficiency Screening, Evaluation, Diagnosis, and Treatment Among at-Risk Childhood Cancer Survivors in the US. Pediatr Blood Cancer. 2026 Jan; 73(1):e32124.
-
Treatment of rapid recurrence of severe steatosis with combined glucagon-like peptide-1 agonist and growth hormone therapy in a pediatric patient transplanted for metabolic dysfunction-associated steatohepatitis cirrhosis in the setting of hypopituitarism. Am J Transplant. 2025 May; 25(5):1123-1126.
-
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty. J Clin Psychopharmacol. 2024 Nov-Dec; 44(6):538-544.
-
Cardiovascular Disorders Associated With Acromegaly: an Update. Endocr Pract. 2024 Dec; 30(12):1212-1219.
-
Evolving growth hormone deficiency: proof of concept. Front Endocrinol (Lausanne). 2024; 15:1398171.
-
Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. BMC Endocr Disord. 2022 Dec 21; 22(1):325.
-
A retrospective analysis of growth hormone therapy in children with Schaaf-Yang syndrome. Clin Genet. 2021 09; 100(3):298-307.
-
Short stature and growth hormone deficiency in a subset of patients with Potocki-Lupski syndrome: Expanding the phenotype of PTLS. Am J Med Genet A. 2020 09; 182(9):2077-2084.
-
Growth hormone signaling and action in obese versus lean human subjects. Am J Physiol Endocrinol Metab. 2019 02 01; 316(2):E333-E344.
-
Growth Hormone Therapy for a Child With Severe Cognitive Impairment. Pediatrics. 2018 10; 142(4).